Erdheim-Chester Disease
Showing 1 - 25 of >10,000
Erdheim-Chester Disease Trial in New York
Recruiting
- Erdheim-Chester Disease
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 7, 2022
Histiocytic Disorder Follow-up Study
Recruiting
- Histiocytosis
- +5 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 13, 2023
Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston
Active, not recruiting
- Langerhans Cell Histiocytosis (LCH)
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 26, 2022
Langerhans Cell Histiocytosis, Erdheim-Chester Disease, LCH Trial in Beijing (HLX208)
Recruiting
- Langerhans Cell Histiocytosis
- +3 more
-
Beijing, ChinaPeking Union Medical College Hospital
Dec 30, 2021
BRAF V600E Mutation Trial run by the NHGRI (Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide)
Completed
- BRAF V600E Mutation
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 6, 2021
Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in
Active, not recruiting
- Rare Histiocytic Disorders (RHDs)
- +7 more
- Registry study
-
Los Angeles, California
- +13 more
Dec 13, 2022
Erdheim-Chester Disease Trial in Houston (Dabrafenib Mesylate, Quality-of-Life Assessment, Questionnaire Administration)
Withdrawn
- Erdheim-Chester Disease
- Dabrafenib Mesylate
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 16, 2021
Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)
Recruiting
- Solid Tumor
- +11 more
-
Belfast, United Kingdom
- +16 more
Mar 2, 2023
Biomarker for Farber Disease (BioFarber)
Active, not recruiting
- Farber's Lipogranulomatosis
- +3 more
-
Cairo, Egypt
- +2 more
May 17, 2021
Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)
Active, not recruiting
- Advanced Malignant Neoplasm
- +38 more
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Memory, Thinking, and Brain Imaging in Adults With Histiocytosis
Active, not recruiting
- Histiocytosis
- Trail Making Test, Parts A & B
- +10 more
-
Basking Ridge, New Jersey
- +3 more
Apr 1, 2022
Erdheim Chester Disease
Completed
- Myelofibrosis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 25, 2019
Farber Disease Natural History Study
Completed
- Farber Disease
- +6 more
-
Oakland, California
- +14 more
Jan 14, 2020
Retroperitoneal Fibrosis, Tocilizumab Treatment Trial in Beijing (Tocilizumab treatment, Prednisone Monotherapy)
Recruiting
- Chronic Periaortitis
- Tocilizumab Monotherapy
- Tocilizumab monotherapy
-
Beijing, ChinaYunyun Fei
Oct 22, 2022
Histiocytosis Trial in Beijing (68Ga-FAPI)
Not yet recruiting
- Histiocytosis
- 68Ga-FAPI
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Mar 25, 2023
Dementia, Acute Medical Event, Hospitalization Trial in Baltimore, Philadelphia (FFC-AC-EIT)
Recruiting
- Dementia
- +2 more
- FFC-AC-EIT
-
Baltimore, Maryland
- +11 more
Jan 10, 2023
Lower Extremity Fixation In Neuropathic Patients Study
Terminated
- Neuropathy
- Charcot; Disease (Etiology)
- SALVATION™ EXTERNAL FIXATION
-
Trinity, Florida
- +2 more
Jan 4, 2023
Histiocytosis Trial in Warsaw (fluorodeoxyglucose (18F-FDG))
Recruiting
- Histiocytosis
- fluorodeoxyglucose (18F-FDG)
-
Warsaw, Mazovian, PolandMother and Child Institute
Aug 2, 2022
Histiocytosis Trial in Warsaw (Vemurafenib)
Recruiting
- Histiocytosis
-
Warsaw, Mazovian, PolandMother and Child Institute
Aug 2, 2022
Uptake and Biodistribution of 18F-fluorocholine in Histiocytic
Completed
- Erdheim-Chester Disease
- +2 more
- F-choline PET Scan
- +2 more
-
New York, New YorkMemoral Sloan Kettering Cancer Center
Aug 28, 2018
Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)
Recruiting
- Kaposiform Hemangioendothelioma
- Kasabach-Merritt Syndrome
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Oct 21, 2022
Persona Revision Knee System Outcomes
Recruiting
- Arthroplasty Complications
- +3 more
- Persona Revision Knee System
-
Fayetteville, Arkansas
- +12 more
May 9, 2022